Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
Neuro-Oncology|December 22, 2021
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Ophthalmology|July 7, 2007
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?Dan S Gombos, John Hungerford, David H Abramson, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Pediatric Blood & Cancer|September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomesSameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Ophthalmology Science|October 17, 2022
Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in RetinoblastomaDavid H Abramson, Diana Mandelker, Jasmine H Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Neuro-Oncology|April 17, 2025
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cold Spring Harbor Molecular Case Studies|December 16, 2018
A recurrent novel <i>MGA-NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcomaDaniel Diolaiti, Filemon S Dela Cruz, Gunes Gundem, et al.
Plos One|February 3, 2023
Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot studyDavid H Abramson, Diana L Mandelker, A Rose Brannon, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Neuro-Oncology|December 22, 2021
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Ophthalmology|July 7, 2007
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?Dan S Gombos, John Hungerford, David H Abramson, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Pediatric Blood & Cancer|September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomesSameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Ophthalmology Science|October 17, 2022
Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in RetinoblastomaDavid H Abramson, Diana Mandelker, Jasmine H Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Neuro-Oncology|April 17, 2025
A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cold Spring Harbor Molecular Case Studies|December 16, 2018
A recurrent novel <i>MGA-NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcomaDaniel Diolaiti, Filemon S Dela Cruz, Gunes Gundem, et al.
Plos One|February 3, 2023
Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot studyDavid H Abramson, Diana L Mandelker, A Rose Brannon, et al.
Pageof 24